Search - tctmd.com

Displaying 501 - 520 of 679

Sort: Relevancy | Date

News Daily News

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

Todd Neale

October 10, 2014

News Daily News

Registro MARIS: El Stent de Nitinol Parece Seguro y Efectivo en Pacientes AFS del ‘Mundo Real’

October 03, 2014

News Daily News

MARIS Registry: Nitinol Stent Appears Safe, Effective in ‘Real World’ SFA Patients

October 03, 2014

News Daily News

Majority of Stable CAD Patients Misunderstand Purpose of PCI

L.A. McKeown

October 03, 2014

News Daily News

La Inmensa Mayoría de Pacientes con EAC Estable No Entienden el Propósito de una PCI

L.A. McKeown

October 03, 2014

News Industry News

Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-Stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease

September 16, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Conference News TCT 2014

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

September 15, 2014

News Conference News TCT 2014

TCT Course Director Outlines Current TAVR Controversies

September 14, 2014

News Conference News TCT 2014

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

September 13, 2014

News Daily News

Link Between PCI Volume and Outcomes Remains Intact

Todd Neale

September 13, 2014

News Conference News TCT 2014

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

September 13, 2014

News Daily News

Initial Thrombolysis Found to Be the Most Costly Strategy for Acute Limb Ischemia

September 08, 2014

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Conference News ESC 2014

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Todd Neale

September 02, 2014

News Industry News

Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG

September 02, 2014

News Conference News ESC 2014

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Todd Neale

September 01, 2014

News Conference News ESC 2014

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Todd Neale

September 01, 2014

News Industry News

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

August 30, 2014

News Industry News

Published robotic PCI study reveals favorable results with respect to patient radiation exposure, fluoroscopy time, and contrast volume

August 07, 2014

Advertisement

Drug-Eluting Balloon Fails for Below-the-Knee Lesions in Critical Limb Ischemia Patients

Registro MARIS: El Stent de Nitinol Parece Seguro y Efectivo en Pacientes AFS del ‘Mundo Real’

MARIS Registry: Nitinol Stent Appears Safe, Effective in ‘Real World’ SFA Patients

Majority of Stable CAD Patients Misunderstand Purpose of PCI

La Inmensa Mayoría de Pacientes con EAC Estable No Entienden el Propósito de una PCI

Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-Stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

EES Decrease Restenosis, TVR vs. BMS in Non-STEMI

TCT Course Director Outlines Current TAVR Controversies

SYMPLICITY HTN-3: Crossover Patients Strengthen the Case for Renal Denervation

Link Between PCI Volume and Outcomes Remains Intact

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

Initial Thrombolysis Found to Be the Most Costly Strategy for Acute Limb Ischemia

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

IBIS-4: High-Dose Statin Therapy May Reverse Atherosclerosis in STEMI

Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

Published robotic PCI study reveals favorable results with respect to patient radiation exposure, fluoroscopy time, and contrast volume

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content